Nicola Milne
Overview
Explore the profile of Nicola Milne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seidu S, Avery L, Bell H, Brown P, Diggle J, Down S, et al.
Diabet Med
. 2024 Dec;
42(3):e15500.
PMID: 39676327
Aims: This expert consensus reviews the reality of primary care clinical management of people with type 2 diabetes (T2D) on non-intensive insulin therapy, with an emphasis on the use of...
2.
Ghosal S, Stanmore E, Sturt J, Bogosian A, Woodcock D, Zhang M, et al.
BMJ Open
. 2024 Nov;
14(11):e088576.
PMID: 39613448
Introduction: People with type 2 diabetes can experience diabetes distress which can negatively affect health outcomes. Non-pharmacological interventions such as mindfulness can help address diabetes distress. However, face-to-face programmes can...
3.
Dasgupta I, Zac-Varghese S, Chaudhry K, McCafferty K, Winocour P, Chowdhury T, et al.
Diabet Med
. 2024 Oct;
42(2):e15450.
PMID: 39415639
A growing and significant number of people with diabetes develop chronic kidney disease (CKD). Diabetes-related CKD is a leading cause of end-stage kidney disease (ESKD) and people with diabetes and...
4.
Rutter M, Carr M, Wright A, Kanumilli N, Milne N, Jones E, et al.
Diabetes Res Clin Pract
. 2024 May;
212:111693.
PMID: 38719027
The COVID-19 pandemic has caused major disruptions in clinical services for people with chronic long-term conditions. In this narrative review, we assess the indirect impacts of the COVID-19 pandemic on...
5.
Seidu S, Alabraba V, Davies S, Newland-Jones P, Fernando K, Bain S, et al.
Diabetes Ther
. 2024 Apr;
15(5):1099-1124.
PMID: 38578397
A substantial evidence base supports the use of sodium-glucose cotransporter-2 inhibitors (SGLT2is) in the treatment of type 2 diabetes mellitus (T2DM). This class of medicines has demonstrated important benefits that...
6.
Goldthorpe J, Allen T, Brooks J, Kontopantelis E, Holland F, Moss C, et al.
JMIR Res Protoc
. 2022 Aug;
11(8):e26237.
PMID: 35976184
Background: Type 2 Diabetes (T2D) is common, with a prevalence of approximately 7% of the population in the United Kingdom. The quality of T2D care is inconsistent across the United...
7.
Bacon M, Appleton R, Bangalore H, Brand C, Browning J, Chin R, et al.
Arch Dis Child Educ Pract Ed
. 2022 Jun;
108(1):43-48.
PMID: 35732467
No abstract available.
8.
Carr M, Wright A, Leelarathna L, Thabit H, Milne N, Kanumilli N, et al.
BMJ Qual Saf
. 2021 Oct;
31(7):503-514.
PMID: 34642228
Objective: To compare rates of performing National Institute for Health and Care Excellence-recommended health checks and prescribing in people with type 2 diabetes (T2D), before and after the first COVID-19...
9.
Carr M, Wright A, Leelarathna L, Thabit H, Milne N, Kanumilli N, et al.
Lancet Diabetes Endocrinol
. 2021 May;
9(7):413-415.
PMID: 33989537
No abstract available.
10.
Wheeler D, James J, Patel D, Viljoen A, Ali A, Evans M, et al.
Diabetes Ther
. 2020 Sep;
11(12):2757-2774.
PMID: 32996085
Diabetic kidney disease (DKD) is a topic of increasing concern among clinicians involved in the management of type 2 diabetes mellitus (T2DM). It is a progressive and costly complication associated...